Werther G A, Haynes K M, Barnard R, Waters M J
Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Australia.
J Clin Endocrinol Metab. 1990 Jun;70(6):1725-31. doi: 10.1210/jcem-70-6-1725.
The sites of action of GH in the human infant remain unclear; recent evidence in animals suggests direct actions on growth plate and other tissues. We have used a monoclonal antibody recognizing the human GH receptor to visually identify and localize GH receptors in the human infant growth plate. Sternochondral cartilage was obtained at postmortem from infants dying of sudden infant death (n = 20), and either decalcified, fixed, and cut into longitudinal sections or digested with collagenase for monolayer culture of chondrocytes. Sections of cultured chondrocytes were stained immunocytochemically with a monoclonal antibody recognizing human GH receptor (MAb 263), using an avidin-biotin system. Sternochondral cartilage was also obtained at operation from adolescents undergoing sternochondroplasty. In infant tissue, GH receptor was identified in sections in chondrocytes of the proliferative and hypertrophic layers, in perichondrium, in osteocytes in new bone, and in hemopoietic precursor cells in marrow. Cultured chondrocytes showed heterogeneous staining for GH receptor. With prolonged culture from 5-8 days, the pattern of staining changed from individual cells to groups of cells. [125I]Human (h)GH showed specific binding to chondrocyte monolayer (0.6 +/- 0.3%), confirmed visually on emulsion autoradiography. In support of specificity of MAb263, it was able to displace [125I]hGH from monolayers by 35%. Adolescent cultured chondrocytes failed to demonstrate specific binding of [125I]hGH. We conclude that GH receptors are widely distributed in a range of mesenchyme cells in the human infant growth plate, including bone and hemopoietic precursors. The expression of these receptors appears to be maturation dependent in both intact tissue and culture, while they may no longer be expressed after the peak growth phase of puberty.
生长激素(GH)在人类婴儿体内的作用位点仍不明确;近期动物实验证据表明其对生长板及其他组织有直接作用。我们使用一种识别人类GH受体的单克隆抗体,在人类婴儿生长板中直观地鉴定并定位GH受体。取自因婴儿猝死综合征死亡的婴儿(n = 20)的胸骨软骨,经脱钙、固定后切成纵切片,或用胶原酶消化用于软骨细胞单层培养。培养的软骨细胞切片使用抗生物素蛋白-生物素系统,用识别人类GH受体的单克隆抗体(单克隆抗体263)进行免疫细胞化学染色。胸骨软骨也取自接受胸骨成形术的青少年患者的手术标本。在婴儿组织中,在增殖层和肥大层的软骨细胞、软骨膜、新骨中的骨细胞以及骨髓中的造血前体细胞的切片中均鉴定出GH受体。培养的软骨细胞对GH受体呈异质性染色。随着培养时间从5天延长至8天,染色模式从单个细胞变为细胞群。[125I]人(h)GH显示出与软骨细胞单层的特异性结合(0.6±0.3%),在乳胶放射自显影上得到直观证实。为支持单克隆抗体263的特异性,它能使[125I]hGH从单层中被置换35%。青少年培养的软骨细胞未能显示出[125I]hGH的特异性结合。我们得出结论,GH受体广泛分布于人类婴儿生长板的一系列间充质细胞中,包括骨和造血前体细胞。这些受体的表达在完整组织和培养中似乎都依赖于成熟度,而在青春期生长高峰期过后可能不再表达。